We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Platform Combines Imaging Scans and Clinical Information Systems for Decision Support

By MedImaging International staff writers
Posted on 27 Dec 2016
Image: The Quantitative Imaging Decision Support (QIDS) software platform (Photo courtesy of Healthmyne).
Image: The Quantitative Imaging Decision Support (QIDS) software platform (Photo courtesy of Healthmyne).
A US company has showcased a new software platform that brings together Electronic Health Record (EHR) and imaging information for analytics and clinical decision support for radiology and oncology specialties.

The platform combines imaging data, and clinical information sources such as Electronic Medical Records (EMR) and Radio Therapy (RT) data into the primary reading workflow. The platform is designed to improve clinical productivity and has been cleared by the US FDA.

The Quantitative Imaging Decision Support (QIDS) software platform was showcased at the annual Radiological Society of North America (RSNA2016) meeting by HealthMyne (Madison, WI, USA). The software provides curated medical content, evidence-based analysis, and reporting for clinical collaboration and improved patient management, as well as data mining for research purposes. The platform is built around an image analysis engine that generates lung cancer screening information such as tumor size, and Lung-RADS categories, amongst other advanced quantitative metrics. HealthMyne plans to expand the platform to other specialties in the future.

President and CEO of HealthMyne, Arvind Subramanian, said, "Radiologists who efficiently leverage existing clinical systems information and generate new quantitative metrics within the primary read will thrive in the Value-Based world. By automatically providing quantitative data not currently available in the routine clinical workflow, HealthMyne is significantly enhancing collaboration between radiologists and oncologists to deliver precise patient management."

Related Links:
HealthMyne

Biopsy Software
Affirm® Contrast
Adjustable Mobile Barrier
M-458
40/80-Slice CT System
uCT 528
Digital X-Ray Detector Panel
Acuity G4

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.